179 related articles for article (PubMed ID: 21480671)
21. Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides.
Ligeti M; Gündüz O; Magyar A; Kató E; Rónai AZ; Vita C; Varga I; Hudecz F; Tóth G; Borsodi A; Benyhe S
Peptides; 2005 Jul; 26(7):1159-66. PubMed ID: 15949634
[TBL] [Abstract][Full Text] [Related]
22. EGF receptor-targeting peptide conjugate incorporating a near-IR fluorescent dye and a novel 1,4,7-triazacyclononane-based (64)Cu(II) chelator assembled via click chemistry.
Viehweger K; Barbaro L; García KP; Joshi T; Geipel G; Steinbach J; Stephan H; Spiccia L; Graham B
Bioconjug Chem; 2014 May; 25(5):1011-22. PubMed ID: 24758412
[TBL] [Abstract][Full Text] [Related]
23. Spectrophotometric determination and removal of unchelated europium ions from solutions containing Eu-diethylenetriaminepentaacetic acid chelate-peptide conjugates.
Elshan NG; Patek R; Vagner J; Mash EA
Anal Biochem; 2014 Nov; 464():24-9. PubMed ID: 25058927
[TBL] [Abstract][Full Text] [Related]
24. Analysis of nonlinear quenching of terbium(III):dipicolinic acid complex fluorescence by chelators and chelate-conjugated macromolecules.
Sanny CG; Price JA
Bioconjug Chem; 1999; 10(1):141-5. PubMed ID: 9893976
[TBL] [Abstract][Full Text] [Related]
25. Exploration of labeling by near infrared dyes of the polyproline linker for bivalent-type CXCR4 ligands.
Nomura W; Aikawa H; Taketomi S; Tanabe M; Mizuguchi T; Tamamura H
Bioorg Med Chem; 2015 Nov; 23(21):6967-73. PubMed ID: 26453409
[TBL] [Abstract][Full Text] [Related]
26. A derivative of diethylenetriaminepentaacetic acid for europium labeling of proteins.
Lee RT; Lee YC
Bioconjug Chem; 2001; 12(6):845-9. PubMed ID: 11716672
[TBL] [Abstract][Full Text] [Related]
27. A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.
Schoofs G; Van Hout A; D'huys T; Schols D; Van Loy T
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578516
[TBL] [Abstract][Full Text] [Related]
28. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
29. Significance of (111)In-DTPA chelate in renal radioactivity levels of (111)In-DTPA-conjugated peptides.
Akizawa H; Arano Y; Mifune M; Iwado A; Saito Y; Uehara T; Ono M; Fujioka Y; Ogawa K; Kiso Y; Saji H
Nucl Med Biol; 2001 May; 28(4):459-68. PubMed ID: 11395320
[TBL] [Abstract][Full Text] [Related]
30. High affinity CXCR4 inhibitors generated by linking low affinity peptides.
Zhang C; Huang LS; Zhu R; Meng Q; Zhu S; Xu Y; Zhang H; Fang X; Zhang X; Zhou J; Schooley RT; Yang X; Huang Z; An J
Eur J Med Chem; 2019 Jun; 172():174-185. PubMed ID: 30978562
[TBL] [Abstract][Full Text] [Related]
31. Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.
Liu N; Wan Q; Cheng Z; Chen Y
Curr Top Med Chem; 2019; 19(1):17-32. PubMed ID: 30706786
[TBL] [Abstract][Full Text] [Related]
32. Aminopropargyl derivative of terpyridine-bis(methyl-enamine) tetraacetic acid chelate of europium (Eu (TMT)-AP3): a new reagent for fluorescent labelling of proteins and peptides.
Poupart S; Boudou C; Peixoto P; Massonneau M; Renard PY; Romieu A
Org Biomol Chem; 2006 Nov; 4(22):4165-77. PubMed ID: 17312973
[TBL] [Abstract][Full Text] [Related]
33. Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).
Oishi S; Fujii N
Org Biomol Chem; 2012 Aug; 10(30):5720-31. PubMed ID: 22517031
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
[TBL] [Abstract][Full Text] [Related]
35. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.
Wang J; He L; Combs CA; Roderiquez G; Norcross MA
Mol Cancer Ther; 2006 Oct; 5(10):2474-83. PubMed ID: 17041091
[TBL] [Abstract][Full Text] [Related]
36. Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression.
Nomura W; Koseki T; Ohashi N; Mizuguchi T; Tamamura H
Org Biomol Chem; 2015 Aug; 13(32):8734-9. PubMed ID: 26186480
[TBL] [Abstract][Full Text] [Related]
37. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
[TBL] [Abstract][Full Text] [Related]
38. A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging.
Sano K; Masuda R; Hisada H; Oishi S; Shimokawa K; Ono M; Fujii N; Saji H; Mukai T
Bioorg Med Chem Lett; 2014 Mar; 24(5):1386-8. PubMed ID: 24491461
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.
van den Berg NS; Buckle T; Kuil J; Wesseling J; van Leeuwen FW
Transl Oncol; 2011 Aug; 4(4):234-40. PubMed ID: 21804919
[TBL] [Abstract][Full Text] [Related]
40.
Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
